RECRUITING

FearLess in NeuroOncology

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The overarching goal of this project is to assess the feasibility, acceptability, and appropriateness of recruitment methods, target population, and a waitlist design to finalize the protocol of FearLess in primary malignant brain tumor patients and caregivers

Official Title

FearLess in Neuro-Oncology

Quick Facts

Study Start:2025-07-01
Study Completion:2028-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06989086

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Self-report a diagnosis of a primary malignant brain tumor (grade II-IV)
  2. * \>2 weeks post-cranial resection or biopsy
  3. * Elevated Fear of Recurrence Distress Rating
  4. * Primarily English speaking
  5. * \>/= 18 years of age at the time of enrollment
  6. * nonprofessional caregiver to a patient with a primary malignant brain tumor (grade II-IV)
  7. * Elevated Fear of Recurrence Distress Rating
  8. * Primarily English speaking
  9. * \>/= 18 years of age at the time of enrollment
  1. * Cognitive impairment that might prohibit active intervention engagement
  2. * Inability to understand and provide informed consent
  3. * Inability to attend virtual sessions due to unstable or no internet connection

Contacts and Locations

Study Contact

Mary Bridgman
CONTACT
804-628-6799
LiveNOW@vcu.edu

Principal Investigator

Ashlee R Loughan, Ph.D
PRINCIPAL_INVESTIGATOR
Virginia Commonwealth University
Sarah E Braun, Ph.D.
PRINCIPAL_INVESTIGATOR
Virginia Commonwealth University

Study Locations (Sites)

Virginia Commonwealth University
Richmond, Virginia, 23298
United States

Collaborators and Investigators

Sponsor: Virginia Commonwealth University

  • Ashlee R Loughan, Ph.D, PRINCIPAL_INVESTIGATOR, Virginia Commonwealth University
  • Sarah E Braun, Ph.D., PRINCIPAL_INVESTIGATOR, Virginia Commonwealth University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-07-01
Study Completion Date2028-12-31

Study Record Updates

Study Start Date2025-07-01
Study Completion Date2028-12-31

Terms related to this study

Keywords Provided by Researchers

  • brain tumor

Additional Relevant MeSH Terms

  • Primary Malignant Brain Tumor
  • Glioblastoma (GBM)
  • Astrocytoma
  • Oligodendroglioma
  • Caregiver